EU simplifies rules on variations
This article was originally published in Scrip
TheEuropean Commission has introduced new, more streamlined rules on variations to marketing authorisations. The new rules, which are outlined in a regulation just published by the commission, include a "do and tell" notification procedure for most minor changes and will apply from January 1st, 2010.
You may also be interested in...
Under EU rules, once a medicinal product has been placed on the market in a country of the EEA – the EU plus Iceland, Liechtenstein and Norway
The EU pharmaceutical strategy published on 25 November will be the first step in a “complete overhaul” of the medicines legislative framework to be proposed in about two years’ time, says the European Commission.
EU and UK regulators are vying for vaccine filings, and the EMA will consider changing the terms of the marketing authorization for remdesivir after a WHO panel advised against its use in COVID-19. An Austrian biotech firm is investigating the prophylactic potential of a carrageenan-based spray.